PureTech Health PLC (PRTC)
Official siteBIOTECHNOLOGY
Last updated: Nov 06, 2026 at 4:00 PM ET
Earnings
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the 50-day average is above the 200-day average. The 14-day RSI is 51.8, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about PRTC
News
No news available
Company news will appear here when available
PRTC Valuation
- P/B
- 0.1x
PRTC Profitability: Margins, ROIC and FCF
PureTech Health (PRTC) has a gross margin of 193.5%. It posts -14.6% ROIC.
- Gross margin
- 193.5%
- ROIC
- -14.6%
PureTech Health Competitors
Peers by sector and size for PureTech Health (PRTC) include Biomea Fusion, Ekso Bionics Holdings and Dogwood Therapeutics.
Sector: Healthcare
PRTC Bull Case vs Bear Case
Bull case
- PRTC beat EPS estimates in 87.5% of its last 8 reported quarters.
PRTC Earnings: Beat Rate
- Beat rate
- 7 of 8 quarters (87.5%)
- Average surprise
- 58.4%
PRTC Earnings Call
The latest PRTC earnings call transcript on file is labeled 2025Q2.
Read the 2025Q2 transcriptUpdated May 6, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About PRTC
Does PRTC pay dividends?
PureTech Health PLC (PRTC) does not currently pay a regular dividend.
PRTC pages: Overview, Financials
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.